help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-1365
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prudente, S.
Right arrow Articles by Trischitta, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prudente, S.
Right arrow Articles by Trischitta, V.
Related Collections
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 1 190-196
Copyright © 2009 by The Endocrine Society

The TRIB3 Q84R Polymorphism and Risk of Early-Onset Type 2 Diabetes

Sabrina Prudente, Daniela Scarpelli, Manisha Chandalia, Yuan-Yuan Zhang, Eleonora Morini, Silvia Del Guerra, Francesco Perticone, Rong Li, Christine Powers, Francesco Andreozzi, Piero Marchetti, Bruno Dallapiccola, Nicola Abate1, Alessandro Doria1, Giorgio Sesti1 and Vincenzo Trischitta1

CSS-Mendel Institute (S.P., E.M., B.D., V.T.), 00198 Rome, Italy; Research Unit of Diabetes and Endocrine Diseases (S.P., V.T.) and Unit of Endocrinology (V.T.), CSS Scientific Institute, 71013 San Giovanni Rotondo, Italy; Department of Experimental and Clinical Medicine (D.S., F.P., F.A., G.S.), University Magna Græcia, 88100 Catanzaro, Italy; Department of Internal Medicine (M.C., R.L., N.A.) and The Center for Human Nutrition (M.C., R.L., N.A.), University of Texas Southwestern Medical Center, Dallas, Texas 75390; Research Division (Y.-Y.Z., C.P., A.D.), Joslin Diabetes Center, Boston, Massachusetts 02215; Department of Medicine (Y.-Y.Z., A.D.), Harvard Medical School, Boston, Massachusetts 02114; Departments of Clinical Sciences (E.M., V.T.) and Experimental Medicine and Pathology (B.D.), "Sapienza" University, 00161 Rome, Italy; and Department of Endocrinology and Metabolism (S.D.G., P.M.), Metabolic Unit, Ospedale Cisanello, University of Pisa, 56127 Pisa, Italy

Address all correspondence and requests for reprints to: Vincenzo Trischitta, M.D., CSS-Mendel Institute, Viale Regina Margherita 261, 00198 Rome, Italy. E-mail: vincenzo.trischitta{at}uniroma1.it.

Context: The prevalence of type 2 diabetes (T2D), particularly among young adults, has been rising steadily during the past 2 decades. T2D, especially in its early-onset subtype, is under genetic control. TRIB3 inhibits insulin-stimulated Akt phosphorylation and subsequent insulin action. A TRIB3 gain-of-function polymorphism, Q84R (rs2295490), impairs insulin signaling.

Objective: The objective of the study was to verify the association of TRIB3 Q84R with: 1) T2D, either subtyped or not according to age at diagnosis (early-onset, <45 yr, or ≥ 45 yr); 2) insulin secretion and sensitivity in nondiabetic individuals; or 3) in vitro insulin secretion from isolated human islets.

Design: Four different case-control samples comprising a total of 5469 whites were examined. Insulinogenic and insulin sensitivity indexes and their interplay (disposition index) were assessed in 645 nondiabetic individuals at oral glucose tolerance test, glucose (16.7 mmol/liter)-induced in vitro insulin secretion was assessed in islets isolated from 54 nondiabetic donors.

Results: In the whole sample, the R84 variant was nominally associated with T2D (odds ratio 1.17, 95% confidence interval 1.00–1.36, P = 0.04). When stratifying according to age of diabetes onset, R84 carriers had an increased risk of early-onset T2D (odds ratio 1.32, 95% confidence interval 1.10–1.58, P = 0.002). Among 645 nondiabetic subjects, R84 carriers had higher glucose levels (P = 0.005) and lower insulinogenic (P = 0.03) and disposition index (P = 0.02) during the oral glucose tolerance test. R84 islets were more likely to display relatively low glucose-stimulated insulin release (P = 0.04).

Conclusions: The TRIB3 R84 variant is associated with early-onset T2D in whites. Alteration in the insulin secretion/insulin sensitivity interplay appears to underlie this association.




This article has been cited by other articles:


Home page
Diabetes CareHome page
H.-p. Gong, Z.-h. Wang, H. Jiang, N.-n. Fang, J.-s. Li, Y.-y. Shang, Y. Zhang, M. Zhong, and W. Zhang
TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis
Diabetes Care, July 1, 2009; 32(7): 1311 - 1313.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society